Style | Citing Format |
---|---|
MLA | Shaygannejad V, et al.. "Immune Thrombocytopenia (Itp) in a Patient With Relapsing-Remitting Multiple Sclerosis (Rrms) Associated With B-Interferon-1Α Treatment." Indian Journal of Pharmaceutical Education and Research, vol. 52, no. 3, 2018, pp. 540-542. |
APA | Shaygannejad V, Fayyazi E, Mirmosayyeb O, Toghianifar N (2018). Immune Thrombocytopenia (Itp) in a Patient With Relapsing-Remitting Multiple Sclerosis (Rrms) Associated With B-Interferon-1Α Treatment. Indian Journal of Pharmaceutical Education and Research, 52(3), 540-542. |
Chicago | Shaygannejad V, Fayyazi E, Mirmosayyeb O, Toghianifar N. "Immune Thrombocytopenia (Itp) in a Patient With Relapsing-Remitting Multiple Sclerosis (Rrms) Associated With B-Interferon-1Α Treatment." Indian Journal of Pharmaceutical Education and Research 52, no. 3 (2018): 540-542. |
Harvard | Shaygannejad V et al. (2018) 'Immune Thrombocytopenia (Itp) in a Patient With Relapsing-Remitting Multiple Sclerosis (Rrms) Associated With B-Interferon-1Α Treatment', Indian Journal of Pharmaceutical Education and Research, 52(3), pp. 540-542. |
Vancouver | Shaygannejad V, Fayyazi E, Mirmosayyeb O, Toghianifar N. Immune Thrombocytopenia (Itp) in a Patient With Relapsing-Remitting Multiple Sclerosis (Rrms) Associated With B-Interferon-1Α Treatment. Indian Journal of Pharmaceutical Education and Research. 2018;52(3):540-542. |
BibTex | @article{ author = {Shaygannejad V and Fayyazi E and Mirmosayyeb O and Toghianifar N}, title = {Immune Thrombocytopenia (Itp) in a Patient With Relapsing-Remitting Multiple Sclerosis (Rrms) Associated With B-Interferon-1Α Treatment}, journal = {Indian Journal of Pharmaceutical Education and Research}, volume = {52}, number = {3}, pages = {540-542}, year = {2018} } |
RIS | TY - JOUR AU - Shaygannejad V AU - Fayyazi E AU - Mirmosayyeb O AU - Toghianifar N TI - Immune Thrombocytopenia (Itp) in a Patient With Relapsing-Remitting Multiple Sclerosis (Rrms) Associated With B-Interferon-1Α Treatment JO - Indian Journal of Pharmaceutical Education and Research VL - 52 IS - 3 SP - 540 EP - 542 PY - 2018 ER - |